Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s): CPHRF

Healthcare

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.

TSX:CPH - Post by User

Cipher Pharmaceuticals Inc

<< Previous

Bullboard Posts

Next >>

Post by SouthernTierTomon Jan 18, 2021 10:43am

202 Views

Post# 32319440

Bullboared Icing on fluffy NR??

Looks interesting to me...

27M shares o/s and a market cap of <25M CAD

Pay attention to the "commentary" here on the Canadien BULL network.

Hmmmmmmmmm???

I've seen lat Friday night NR's in my time, often a choice to make it look as though.."We hope nobody sees it"

If we were playing poker, and really we are...I think somebody is attempting a rather weak bluff ; - )

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario